Therapeutic Asset Ratings
147 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
ngm438
Cervical Cancer
NGM Biopharmaceuticals, Inc
P1
C
(37)
ngm831
Cervical Cancer
NGM Biopharmaceuticals, Inc
P1
C
(37)
Nrm-823
Cervical Cancer
Normunity AccelCo, Inc.
P1
C
(37)
Phn-010
Cervical Cancer
Pheon Therapeutics
P1
C
(37)
Pyrotinib
Cervical Cancer
HiFiBiO Therapeutics
P1
C
(37)
rad301
Cervical Cancer
Radiopharm Theranostics, Ltd
P1
C
(37)
rc48-adc
Cervical Cancer
HiFiBiO Therapeutics
P1
C
(37)
Rgt-490
Cervical Cancer
Regor Pharmaceuticals Inc.
P1
C
(37)
Rndo-564
Cervical Cancer
Rondo Therapeutics
P1
C
(37)
scg142 tcr-t cells
Cervical Cancer
The Affiliated Hospital of Qingdao University
P1
C
(37)
Stro-004
Cervical Cancer
Sutro Biopharma, Inc.
P1
C
(37)
Tislelizumab
Cervical Cancer
HiFiBiO Therapeutics
P1
C
(37)
Tsc-200-A0201
Cervical Cancer
TScan Therapeutics, Inc.
P1
C
(37)
Tsc-201-B0702
Cervical Cancer
TScan Therapeutics, Inc.
P1
C
(37)
Tsc-202-A0201
Cervical Cancer
TScan Therapeutics, Inc.
P1
C
(37)
Tsc-203-A0201
Cervical Cancer
TScan Therapeutics, Inc.
P1
C
(37)
Tsc-204-A0101
Cervical Cancer
TScan Therapeutics, Inc.
P1
C
(37)
Tsc-204-A0201
Cervical Cancer
TScan Therapeutics, Inc.
P1
C
(37)
Tsc-204-C0702
Cervical Cancer
TScan Therapeutics, Inc.
P1
C
(37)
vet3-tgi
Cervical Cancer
KaliVir Immunotherapeutics
P1
C
(37)
Tcr-T Cells
Cervical Cancer
Beijing Geekgene Technology Co., LTD
D
(28)
Trastuzumab Deruxtecan
Cervical Cancer
AstraZeneca
D
(28)
Showing 126 to 147 of 147 assets
Previous
Page 6 of 6
Next
